Showing results (601-610 of 629) with videos related to
Sort By:
Pageof 63
Plos One|July 26, 2017
Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in TaiwanTsung-Hsing Hung, Chih-Ming Liang, Chien-Ning Hsu, et al.Redox Biology|August 20, 2017
Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O<sup>6</sup>-methylguanine-DNA methyltransferaseKwang-Yu Chang, Tsung-I Hsu, Che-Chia Hsu, et al.The American Journal of Gastroenterology|June 25, 2025
Vonoprazan High-Dose Dual, Vonoprazan Triple, and Rabeprazole Reverse Hybrid Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter Randomized TrialPing-I Hsu, Chien-Lin Chen, Chih-An Shih, et al.Medicine|September 8, 2016
Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: A nationwide cohort studyChih-Ming Liang, Chien-Ning Hsu, Wei-Chen Tai, et al.Journal of Biomedical Science|October 21, 2019
Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsetsChia-Hung Chien, Jian-Ying Chuang, Shun-Tai Yang, et al.BMC Gastroenterology|March 1, 2018
Gallbladder function predicts subsequent biliary complications in patients with common bile duct stones after endoscopic treatment?Tzung-Jiun Tsai, Hoi-Hung Chan, Kwok-Hung Lai, et al.Infection and Drug Resistance|October 2, 2019
A comparison between dexlansoprazole modified release-based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line <i>Helicobacter pylori</i> eradication: a prospective randomized trialWei-Chen Tai, Chih-Ming Liang, Kuo-Wei Bi, et al.Journal of Medicinal Chemistry|January 21, 2025
Repurposing Linezolid in Conjunction with Histone Deacetylase Inhibitor Access in the Realm of Glioblastoma TherapiesI-Chung Chen, Hong-Yi Lin, Zheng-Yang Liu, et al.Cell Stem Cell|November 3, 2018
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic ChemotherapyJoanne I Hsu, Tajhal Dayaram, Ayala Tovy, et al.Oncotarget|May 21, 2016
MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinomaCheng-Han Lin, Chen-Hsun Tsai, Ching-Tung Yeh, et al.Pageof 63